Generated by All in One SEO v4.9.1.1, this is an llms.txt file, used by LLMs to index the site.

# HESI Thrive

Innovating translational research improving quality of life after cancer

## Sitemaps

- [XML Sitemap](https://hesithrive.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Pages

- [Homepage](https://hesithrive.org/) - Innovating translational research. Improving quality of life after cancer. LEARN MORE The HESI THRIVE Award Cycle The current award cycle is closed for review of the 2026 LOIs 2026 Timeline THRIVE NEWSJoin us in congratulating our 2025 winners! HESI THRIVE charts new futures for cancer patients and survivors by making patient QUALITY OF LIFE an
- [Grant Guidelines](https://hesithrive.org/guidelines/) - GRANT GUIDELINES 2026 THRIVE Award Cycle The current cycle is closed for review of the 2026 submitted LOIs PURPOSE The THRIVE grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and/or other
- [2021 THRIVE Grant Award Winners](https://hesithrive.org/2021-hesi-thrive-grant-award-winners/) - 2021 THRIVE GRANT AWARD WINNERS We are pleased to announce this year's grant award winners, selected from over 50 proposals received from more than 30 different institutions. Each of the winning proposals, listed below, will receive $50,000 in funding to support their research in making cancer patient quality of life an active research priority. 2021
- [Dr. Xiao Vignette](https://hesithrive.org/2021-awardee-xiao/) - Shuo Xiao, PhD, Rutgers University, studies how cancer treatments affect women's reproductive health Why can chemotherapy lead to infertility or early menopause? As Dr. Xiao explains, "Anti-cancer agentswill kill cancer cells… however, the egg …is more sensitive to the side- effects of those anti-cancer agents.That's why young female cancer patients have very high risk of
- [About THRIVE](https://hesithrive.org/about/) - ABOUT HESI THRIVE WHAT IS IT? Treatment related adverse impacts on patient quality of life are not unique to any one oncologic drug class or therapeutic approach and challenge our ability to support the best possible cancer patient outcomes. Despite the opportunity to do better, funding for research in this critical arena has been limited. THRIVE offers
- [2025 THRIVE Grant Award Winners](https://hesithrive.org/2025-thrive-grant-award-winners/) - 2025 THRIVE GRANT AWARD WINNERS THRIVE is a competitive seed grant program designed to support research that helps to predict, reduce, or prevent adverse events associated with life-saving cancer therapy. We are pleased to announce this year's grant award winners, selected from a large pool of highly competitive proposals received from research around the globe.
- [testtime](https://hesithrive.org/testtime/) - GRANT GUIDELINES PURPOSE The THRIVE grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and/or other major granting institutions. 2025 TIMELINE Nov 25, 2024 HESI THRIVE 2025 cycle begins: open call for
- [Why THRIVE](https://hesithrive.org/why/) - WHY THRIVE SURVIVING CANCERWILL TOUCH ALL OF US... 40% of the population will be diagnosed with cancer at some point in their lifetime. There are already 20 Million cancer survivors in the US alone - and increasing as drug efficacy improves. Existing cancer therapies are beneficial and lifesaving - they have given a future to
- [2024 THRIVE Grant Award Winners](https://hesithrive.org/2024-thrive-grant-award-winners/) - 2024 THRIVE GRANT AWARD WINNERS THRIVE is a competitive seed grant program designed to support research that helps to predict, reduce, or prevent adverse events associated with life-saving cancer therapy. We are pleased to announce this year's grant award winners, selected from a large pool of highly competitive proposals received from research around the globe.
- [Advisory Board](https://hesithrive.org/advisory-board/) - ADVISORY BOARD Stephen Lipshultz, MD, FAAP, FAHA Conger Goodyear Professor and Chair of Pediatrics, University at Buffalo. Pediatric Chief-of-Service, Kaleida Health. Medical Director of Pediatric Services Business Development, John R. Oishei Children's Hospital. President, UBMD Pediatrics. Editor in Chief, CardioOncology. Jerry Lee, PhD Chief Science and Innovation Officer, Ellison Institute for Transformative Medicine, University of
- [2023 THRIVE Grant Award Winners](https://hesithrive.org/2023-hesi-thrive-grant-award-winners/) - 2023 THRIVE GRANT AWARD WINNERS THRIVE is a competitive seed grant program designed to support research that helps to predict, reduce, or prevent adverse events associated with life-saving cancer therapy. We are pleased to announce this year's grant award winners, selected from a large pool of highly competitive proposals received from research around the globe.
- [Donate](https://hesithrive.org/donate/) - DONATE $100,000+ IN CONTRIBUTIONS $75,000+ IN CONTRIBUTIONS $50,000+ IN CONTRIBUTIONS $10,000+ IN CONTRIBUTIONS
- [2022 THRIVE Grant Award Winners](https://hesithrive.org/2022-hesi-thrive-grant-award-winners/) - 2022 THRIVE GRANT AWARD WINNERS THRIVE is a competitive seed grant program designed to support research that helps to predict, reduce, or prevent adverse events associated with life-saving cancer therapy. We are pleased to announce this year's grant award winners, selected from a large pool of highly competitive proposals received from research around the globe.
- [2019 THRIVE Grant Award Winners](https://hesithrive.org/2019-hesi-thrive-grant-award-winners/) - 2019 THRIVE GRANT AWARD WINNERS 2019 THRIVE Grant Award Winners HESI THRIVE Research Study: Targeting complement signaling to ameliorate cranial radiation-induced brain injury Dr. Munjal Acharya, Associate Professor Department of Anatomy & Neurobiology, University of California, Irvine Click here to see an overview of this research study HESI THRIVE Research Study: Stop LCNP: High dose
- [2017 THRIVE Grant Award Winners](https://hesithrive.org/2017-hesi-thrive-grant-award-winners/) - 2017 THRIVE GRANT AWARD WINNERS 2017 THRIVE Grant Award Winners HESI THRIVE Research Study: Evaluating co-therapies that may reduce skin and metabolic side effects of glucocorticoids in patients with blood cancers (e.g., leukemia, lymphoma, and myeloma) Irina Budunova, MD, PhD Northwestern University, Feinberg School of Medicine HESI THRIVE Research Study: Defining the genetic profile of
- [Donor Dashboard](https://hesithrive.org/donor-dashboard/) - [give_donor_dashboard]
- [HESI Privacy Policy](https://hesithrive.org/hesi-privacy-policy/) - HESI is committed to honoring the privacy of those who visit our website and engage in activities with us. The Privacy Notice describes how we collect, store, and use information about our members, partners, and website visitors. This Privacy Notice applies to all personal data processed by full-time and part-time employees, volunteers when acting on
- [Post #591](https://hesithrive.org/post-591/)
- [Biden Cancer Summit](https://hesithrive.org/biden-cancer-summit/) - September 21, 2018 HESI is honored to be recognized as a featured contributor to today’s inaugural Biden Cancer Summit in Washington, DC. HESI was selected amongst a pool of national applicants as a leader in developing new innovative programs and partnerships that will double the rate of progress against cancer and improve the cancer patient
- [Donation Confirmation](https://hesithrive.org/donation-confirmation/) - [give_receipt]
- [No Access](https://hesithrive.org/no-access/) - [dlm_no_access]
- [Transaction Failed](https://hesithrive.org/transaction-failed/) - We're sorry, your transaction failed to process. Please try again or contact site support.
- [Donation History](https://hesithrive.org/donation-history/) - [donation_history]
- [HESI THRIVE Network Named as White House Cancer Moonshot Participant](https://hesithrive.org/pressrelease/) - Collaborative Program Will Provide Support for Quality-of-Life Research for Cancer Survivors WASHINGTON – (October 17, 2016) – Vice President Joe Biden released today a final report on the Cancer Moonshot Task Force, naming the Health and Environmental Sciences Institute’s (HESI’s) THRIVE Network as a participant in the Moonshot’s efforts to further advance the task force’s